Mobile menu not yet fully implemented
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
This was 1 year ago
LocationThe Centre de Conférences Albert Borschette (CCAB), Brussels (Hybrid)
ProgrammesThe European Commission is organising hybrid info days for the call topics for 2023 under the 2023-2024 Work Programme of cluster 5.
The current agenda can be consulted on the event site. Parallel sessions include the following destination calls:
As mentioned in the official announcement, the goal of the info days is to present 107 open topics of the Horizon Europe Cluster 5 2023 calls through a plenary and four parallel sessions, with emphasis on:
After the EC's agenda on the first day, a brokerage event will also take place (separate registration required).
Registration for physical attendance can be done through the official info days registration page (yet to be announced).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Cybersecurity Defence EDF NATO-EDA
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.